" "

Pune-based healthtech startup FlexifyMe secures Rs 1Cr investment on Shark Tank India

Sumit Vishwakarma
New Update
FlexifyMe secures funding from Shark Namita Thapar

FlexifyMe secures funding from Shark Namita Thapar

FlexifyME is a Pune-based startup offering a chronic pain management platform that integrates physiotherapy, yoga, and artificial intelligence (AI) to provide customized treatment plans. 

The platform uses AI-driven self-assessment through camera vision to generate personalized exercise plans delivered by a combination of yoga therapists, physiotherapists, and AI-based self-practice guides.

FlexifyME aims to make chronic pain management accessible and effective from the comfort of one's home, catering to a global audience with services available in multiple local languages.

In its first year, FlexifyME attracted over 50,000 customers, including 2,000 subscribers from more than 26 countries, demonstrating a significant market demand for innovative solutions in the chronic pain management sector.


Who are the founders?

Pune-based Amit and Manjeet founded FlexifyME. The founders have established It as a pioneering platform in the chronic pain management industry, combining their expertise to address the widespread issue of chronic pain through an innovative blend of physiotherapy, yoga, and artificial intelligence.

How does it work?

The startup aims to address the global issue of chronic pain, which affects over 1.7 billion people worldwide, surpassing the population of India. Chronic pain, including conditions like back pain, neck pain, arthritis, and spondylitis, represents a significant health challenge that often leads to a decreased quality of life and reliance on temporary solutions like painkillers, which can have side effects, or physiotherapy and yoga, which may not always be standardized or correctly practised.

  1. Self-Assessment: The platform begins by self-assessing the user's condition using AI and camera vision technology. This innovative approach allows for a personalized analysis of the user's pain points and movement limitations.
  2. Customized Plan: Based on the assessment report, FlexifyME generates a customized treatment plan that integrates yoga, physiotherapy, and AI-driven self-practice exercises. This plan is tailored to address the specific needs and pain points of the individual.
  3. Home-Based Sessions: One of the key features of FlexifyME is its ability to deliver these comprehensive treatment sessions directly to users' homes. The platform makes it possible for users to follow their personalized treatment plans in their local languages, enhancing accessibility and convenience.
  4. Continuous Monitoring and Adjustment: The platform continuously monitors the user's progress through AI technology and adjusts the treatment plan as needed to ensure optimal outcomes.

Leveraging technology for personalised treatment plans 

FlexifyME is using technology to persoanlised and accessible treatment plans, aiming to change the way people deal with long-lasting pain. They want to make it simpler for people to live without pain, without having to go through surgery or depend on medicine.

How does FlexifyMe make money?

The startup offers a subscription plan that ranges in price, with an average cost between Rs 6,000 and Rs 16,000 for a six-month period. This subscription includes 25 live sessions with a physiotherapist, along with a customized plan that guides users on how many days to dedicate to yoga, physiotherapy, and self-practice exercises.

The pricing structure is designed to provide comprehensive chronic pain management services at a cost that reflects the personalized and technologically advanced approach of the platform.

FlexifyMe's Shark Tank India pitch

In a compelling pitch session, Amit and Manjeet sought Rs 1 crore for a 2% stake, valuing the startup at a robust Rs 50 crore.

After a series of negotiations, the founders struck a deal with investor Namita, settling on a Rs 50 lakh investment for a 1.32% equity share alongside a Rs 50 lakh loan at a 10% interest rate over two years, effectively valuing the company at Rs 37.88 crore. 

Watch the episode below: